SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $673 | -17.1% | 22,400 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $812 | -7.4% | 22,400 | -8.9% | 0.00% | 0.0% |
| Q4 2022 | $877 | -99.9% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $833,000 | +4.0% | 24,600 | -11.2% | 0.00% | 0.0% |
| Q2 2022 | $801,000 | -10.5% | 27,700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $895,000 | +8.1% | 27,700 | -2.5% | 0.00% | +100.0% |
| Q4 2021 | $828,000 | -16.5% | 28,400 | -23.7% | 0.00% | -50.0% |
| Q3 2021 | $992,000 | -83.4% | 37,200 | -80.8% | 0.00% | -80.0% |
| Q2 2021 | $5,964,000 | -77.8% | 193,700 | -81.1% | 0.01% | -78.3% |
| Q1 2021 | $26,816,000 | +4.3% | 1,024,300 | +0.2% | 0.05% | -2.1% |
| Q4 2020 | $25,711,000 | +52.0% | 1,021,900 | +25.9% | 0.05% | +34.3% |
| Q3 2020 | $16,917,000 | +2.3% | 811,800 | +16.6% | 0.04% | +2.9% |
| Q2 2020 | $16,538,000 | +31.3% | 696,366 | -0.6% | 0.03% | +13.3% |
| Q1 2020 | $12,597,000 | -23.2% | 700,266 | +1.3% | 0.03% | +15.4% |
| Q4 2019 | $16,399,000 | -11.1% | 691,366 | +3.0% | 0.03% | -13.3% |
| Q3 2019 | $18,439,000 | +2595.8% | 671,029 | +3141.7% | 0.03% | +2900.0% |
| Q2 2019 | $684,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |